Загрузка...
Efficacy of the monoclonal antibody EGFR inhibitors for the treatment of metastatic colorectal cancer
Two anti-epidermal growth factor receptor (EGFR) monoclonal antibodies (MoAbs) have been approved in Canada for the treatment of metastatic colorectal cancer (mCRC) – cetuximab, a mouse-human chimeric MoAb, and panitumumab, a fully human MoAb. This paper reviews the efficacy of the anti-EGFR monoclo...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Multimed Inc.
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2901794/ https://ncbi.nlm.nih.gov/pubmed/20680105 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|